WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Oncocyte earnings were -$43.6M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest OCX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$13.5M, up 197.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, OCX reported annual earnings of -$28.7M, with -60.9% growth.

OCX earnings history

Current Revenue
$709.0k
Current Earnings
-$43.6M
Current Profit Margin
-6,142.9%

OCX Return on Equity

Current Company
-270.2%
Current Industry
-15.5%
Current Market
36.1%
OCX's Return on Equity (-270.2%)... subscribe to Premium to read more.
High Return on Equity Performance

OCX Return on Assets

Current Company
-59.9%
Current Industry
5.7%
OCX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OCX announces earnings.

OCX Return on Capital Employed

Current Company
-70.57%
Current Industry
10.3%
OCX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OCX vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OCX-$41.81M-$43.55MN/A-$18,083.20
PMAXN/AN/AN/AN/A
STIM-$26.92M-$36.42MN/A-$1.22
PREN/A-$49.01MN/A-$3.99
DRIO-$42.73M-$44.23MN/A-$0.94
View Top Diagnostic & Research Stocks

Oncocyte Earnings Reports & History FAQ

What were Oncocyte's earnings last quarter?

On OCX's earnings call on Invalid Date, Oncocyte (NASDAQ: OCX) reported Q3 2024 earnings per share (EPS) of -$13,493.00, up 101.78% year over year. Total OCX earnings for the quarter were -$13.49 million. In the same quarter last year, Oncocyte's earnings per share (EPS) was -$6,687.00.

If you're new to stock investing, here's how to buy Oncocyte stock.

Is Oncocyte profitable or losing money?

As of the last Oncocyte earnings report, Oncocyte is currently losing money. Oncocyte's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$43.35 million, a 24.48% decrease year over year.

What was OCX's earnings growth in the past year?

As of Oncocyte's earnings date in Invalid Date, Oncocyte's earnings has grown year over year. OCX earnings in the past year totalled -$43.55 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.